Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
12/2000
12/05/2000US6156893 Process for the preparation of (1S,4R)- or (1R,4S)- 4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol
12/05/2000US6156773 Pharmaceutical composition
12/05/2000US6156748 Compounds useful as neuro-protective agents
12/05/2000US6156494 Solid phase synthesis using substrate having regions, each region is an optical fiber having covalently bound reactive groups; fibers are used to direct light, heat or both to compounds tethered to its surface
11/2000
11/30/2000WO2000071529A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/30/2000WO2000071512A1 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071511A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071510A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071509A1 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071508A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071506A2 Naphthalene ureas as glucose uptake enhancers
11/30/2000WO2000071120A1 Antibacterial compounds
11/30/2000WO2000042989A3 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
11/30/2000WO2000038716A9 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
11/30/2000DE19924790A1 Polymerisierbare, olefinisch ungesättigte Monomere Polymerizable, olefinically unsaturated monomers
11/30/2000DE19924050A1 Verfahren zur Herstellung von Alken-Verbindungen Process for the preparation of alkene compounds
11/30/2000CA2382751A1 Inhibitors of factor xa
11/30/2000CA2374947A1 Inhibitors of factor xa
11/30/2000CA2374820A1 Inhibitors of factor xa
11/30/2000CA2374793A1 Inhibitors of factor xa
11/30/2000CA2374650A1 Inhibitors of factor xa
11/30/2000CA2374225A1 Naphthalene ureas as glucose uptake enhancers
11/30/2000CA2372580A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/29/2000EP1055653A2 Process for the preparation of alkenyl compounds
11/29/2000EP1054960A1 Heteroaromatic oligoamides as affinity ligands
11/29/2000EP1054878A1 Azulene hydroxamic acid derivatives as metalloprotein inhibitors
11/29/2000EP1054865A1 Farnesyl transferase inhibitors
11/29/2000CN1275123A Prostaglandin agonists and their use to treat bone disorders
11/29/2000CN1274721A Prepn. of hydroxamic acid
11/28/2000US6153763 A microbicides comprising an imidazole ring
11/28/2000US6153762 Bridged bis-4,5-dihydroxyimidazolidin-2-ones, n-methylolated derivatives thereof, their preparation and crosslinking textiles therewith
11/28/2000US6153630 Phenylpyridyl compounds for inhibiting phosphodiesterase IV and methods of using same
11/28/2000US6153576 Activating peroxygen compound in an oxidizing, washing, cleaning or disinfecting solution, comprising contacting with complexes of transition metals with nitrogen-containing polydentate ligands as activators or catalysts
11/28/2000US6153217 Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
11/23/2000WO2000069853A1 Azole compounds and herbicide compositions
11/23/2000WO2000069830A1 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
11/23/2000WO2000069823A1 Ion channel modulating agents
11/23/2000CA2373590A1 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
11/23/2000CA2373518A1 Azole compounds and herbicide compositions
11/22/2000EP1054003A1 Urocanic acid derivatives
11/22/2000EP1053227A1 Ppar-gamma modulators
11/22/2000EP1053226A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
11/22/2000EP1052986A1 Anti-inflammatory agents
11/22/2000EP1052984A1 Antibacterial agents
11/22/2000CN1274288A Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
11/21/2000US6150530 Amidation of amine with acid
11/21/2000US6150460 Containing an imidazolidin-2-one ring
11/21/2000US6150389 Antidepressants; treating elevated intraocular pressure, e.g., glaucoma; antidiabetic agents for non-insulin dependent diabetes, sexual disorders, e.g., male impotence and obesity; e.g. trans-2-(3-phenyl-bicyclo(2.2.1)heptyl)-2-aminooxazoline
11/21/2000US6150384 Pharmaceutical composition
11/21/2000US6150383 Comprising an insulin sensitivity enhancer in combination with one or more other antidiabetics differing from the enhancer in mechanism of action; lipid/glycometabolism disorders; antidiabetic agents; side effect reduction
11/21/2000US6150378 Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
11/21/2000US6150370 1,3-dinitrocyclic compound treats numerous diseases caused by undesired metalloprotease activity, such as tumor metastasis, osteoarthritis, rheumatoid arthritis, skin inflammation, ulcerations, and periodontitis
11/16/2000WO2000068227A1 Substituted benzoylisoxazoles and the use thereof as herbicides
11/16/2000WO2000068226A1 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds
11/16/2000WO2000068205A1 Process for obtaining a hydroxamic acid
11/16/2000WO2000068204A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
11/16/2000WO2000068185A1 A structure-based approach to design inhibitors of protein-processivity factor interactions
11/16/2000WO2000067746A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000041469A3 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS
11/16/2000WO2000035887A3 Vitronectin receptor antagonist pharmaceuticals
11/16/2000WO2000034437A3 Inhibitors of prenyl-protein transferase
11/16/2000WO2000015634A3 Hiv protease inhibitors
11/16/2000CA2373182A1 A structure-based approach to design inhibitors of protein-processivity factor interactions
11/16/2000CA2373076A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
11/16/2000CA2373010A1 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds
11/16/2000CA2372963A1 Substituted benzoylisoxazoles and the use thereof as herbicides
11/15/2000EP1052249A1 Process for the preparation of hydroxamic acids
11/15/2000EP1051402A1 Method for producing s-alkyl(aryl)-substituted imidazol derivatives
11/15/2000EP1051401A1 Process for the production of formylimidazoles
11/15/2000EP1051400A1 Cyclic alkyleneureas containing monomers and polymers and latices therefrom
11/15/2000EP1051397A1 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound
11/15/2000EP1051169A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
11/15/2000CN1273584A Imidazolyl-cyclic acetals
11/15/2000CN1273581A Method and reagents for N-alkylating ureides
11/15/2000CN1273528A Novel heterocyclic analogs of diphenylethylene compounds
11/14/2000US6147253 N-protected/N-substituted-beta-amino-hydroxy sulfonates
11/14/2000US6147232 Process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives
11/14/2000US6147097 Imidazole derivatives as anti-HIV agents
11/14/2000CA2040370C Insecticidal compositions
11/11/2000CA2307994A1 Process for the preparation of hydroxamic acids
11/09/2000WO2000066597A1 Ionic liquids and production and use thereof
11/09/2000WO2000066578A1 Compounds for the treatment of obesity
11/09/2000WO2000066563A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands
11/09/2000WO2000066522A1 Glucocorticoid receptor modulators
11/09/2000WO2000066120A1 Novel catechols as antimicrobial agents
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
11/09/2000DE19921424A1 Substituierte Benzoylketone Substituted benzoyl ketones
11/09/2000DE19920791A1 Substituierte Benzoylisoxazole Substituted benzoylisoxazoles
11/09/2000DE19919174A1 Verfahren zur Herstellung von Hydantoinen oder cyclischen Anhydriden einer Aminosäure A process for the preparation of hydantoins or cyclic anhydrides of an amino acid
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372173A1 Glucocorticoid receptor modulators
11/09/2000CA2372079A1 Novel catechols as antimicrobial agents
11/08/2000EP1049666A1 Novel naphthyl-substituted and anilide-substituted sulfonamides
11/08/2000EP1049662A1 Inhibitors of alpha4 mediated cell adhesion
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/08/2000CN1058263C Process for preparing methylolhydantoins
11/07/2000US6143901 Complex formation between dsDNA and pyrrole imidazole polyamides
11/07/2000US6143790 Enzyme inhibitors
11/07/2000US6143789 Enantiomorphs
1 ... 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 ... 345